Today, CellaVision announced that the company's Annual Report for 2013 is available as PDF at www.cellavision.com, and can be read via the link below.
To request a printed version, please visit the investor pages at CellaVision's website.
For more information, please contact:
Yvonne Mårtensson, CEO.
Phone: +46 708 33 77 82, e-mail: yvonne.martensson@cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan. In 2013 sales were SEK 180 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com.
Attachments
